InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

- Current share price for IMR : $1.970

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$706 S&P DJI Announces March 2025 Quarterly Rebalance 7 Mar 2025 5:01PM $1.560 $1.970 risen by 26.28%
$706 Submission of Second Module to FDA for PMA Products 4 Mar 2025 9:27AM $1.580 $1.970 risen by 24.68%
$706 FY24 Results Investor Presentation 27 Feb 2025 8:07AM $1.460 $1.970 risen by 34.93%
$706 Imricor Releases FY24 Results 27 Feb 2025 8:07AM $1.460 $1.970 risen by 34.93%
$706 Appendix 4E and FY24 Financial Accounts 27 Feb 2025 8:06AM $1.460 $1.970 risen by 34.93%
$706 CE Mark Approval for 2nd Gen Vision MR Ablation Catheter 19 Feb 2025 9:16AM $1.480 $1.970 risen by 33.11%
$706 FY24 Results Webinar 17 Feb 2025 9:25AM $1.450 $1.970 risen by 35.86%
$706 Cleansing Notice 7 Feb 2025 1:21PM $1.290 $1.970 risen by 52.71%
$706 Application for quotation of securities - IMR 7 Feb 2025 1:16PM $1.285 $1.970 risen by 53.31%
$706 Release from Voluntary Escrow 31 Jan 2025 10:01AM $1.420 $1.970 risen by 38.73%
$706 Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C 23 Jan 2025 9:01AM $1.335 $1.970 risen by 47.57%
$706 Notification regarding unquoted securities - IMR 13 Jan 2025 9:30AM $1.245 $1.970 risen by 58.23%
$706 Notification of cessation of securities - IMR 9 Jan 2025 12:18PM $1.230 $1.970 risen by 60.16%
$706 Clarification Announcement 31 Dec 2024 9:25AM $1.305 $1.970 risen by 50.96%
$706 Imricor Received First Purchase Order in the Middle East 30 Dec 2024 9:04AM $1.170 $1.970 risen by 68.38%
$706 NorthStar Regulatory Update 23 Dec 2024 8:44AM $1.025 $1.970 risen by 92.20%
$706 Imricor Signs License Agreement with ADIS for Northstar 28 Nov 2024 9:29AM $1.070 $1.970 risen by 84.11%
$706 Imricor Performs First Procedure in Switzerland 27 Nov 2024 9:53AM $0.880 $1.970 risen by 123.86%
$706 NorthStar Update 17 Oct 2024 9:38AM $0.610 $1.970 risen by 222.95%
$706 Release from Voluntary Escrow 16 Oct 2024 9:36AM $0.600 $1.970 risen by 228.33%
$706 Imricor Q3 CY24 Quarterly Activities Report and Appendix 4C 16 Oct 2024 9:04AM $0.600 $1.970 risen by 228.33%
$706 Regulatory Update 14 Oct 2024 9:49AM $0.560 $1.970 risen by 251.79%
$706 Notification of cessation of securities - IMR 10 Oct 2024 10:17AM $0.555 $1.970 risen by 254.95%
$706 Notification regarding unquoted securities - IMR 9 Oct 2024 11:23AM $0.550 $1.970 risen by 258.18%
$706 Becoming a substantial holder 25 Sep 2024 9:30AM $0.580 $1.970 risen by 239.66%

126 - 150 of 598 results

Page 6 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.